drugset / Trial / NCT00670813

Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil

NCT00670813

Phase 2 Withdrawn 30 enrolled Technical University of Munich Cephalon · collab
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The study aims to investigate whether the administration of the stimulant modafinil during a 40 hour sleep deprivation period in depressed patients can intensify the antidepressant effect of the sleep deprivation as assessed by a reduction in the Hamilton Depression score (HAMD, 6-item version). We postulate that this also correlates with a reduction of the polysomnographically assessed overall amount of sleep during this period.

Timeline

Start
2008-05
Primary completion
2009-11
Completion
2009-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 200 mg Oral

Indications